Reported Standalone quarterly numbers for Panacea Biotec are:Net Sales at Rs 80.37 crore in March 2024 up 7.13% from Rs. 75.02 crore in March 2023.
Quarterly Net Loss at Rs. 1.37 crore in March 2024 up 93.04% from Rs. 19.69 crore in March 2023.
EBITDA stands at Rs. 7.15 crore in March 2024 down 47.81% from Rs. 13.70 crore in March 2023.
| Panacea Biotec shares closed at 127.75 on June 06, 2024 (NSE) and has given -25.44% returns over the last 6 months and 6.55% over the last 12 months. |
| Panacea Biotec | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'24 | Dec'23 | Mar'23 | | Net Sales/Income from operations | 80.37 | 95.23 | 75.02 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 80.37 | 95.23 | 75.02 | | EXPENDITURE | | Consumption of Raw Materials | 26.09 | 23.56 | 36.16 | | Purchase of Traded Goods | -- | -- | 0.75 | | Increase/Decrease in Stocks | 0.94 | 20.30 | -6.00 | | Power & Fuel | -- | -- | -- | | Employees Cost | 23.29 | 20.84 | 19.03 | | Depreciation | 5.14 | 5.21 | 5.90 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 39.29 | 23.89 | 21.65 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -14.38 | 1.43 | -2.47 | | Other Income | 16.39 | 3.05 | 10.27 | | P/L Before Int., Excpt. Items & Tax | 2.01 | 4.48 | 7.80 | | Interest | 3.36 | 3.41 | 2.70 | | P/L Before Exceptional Items & Tax | -1.35 | 1.07 | 5.10 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -1.35 | 1.07 | 5.10 | | Tax | 0.02 | 0.64 | 24.79 | | P/L After Tax from Ordinary Activities | -1.37 | 0.43 | -19.69 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -1.37 | 0.43 | -19.69 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.22 | 0.07 | -3.21 | | Diluted EPS | -0.22 | 0.07 | -3.21 | | EPS After Extra Ordinary | | Basic EPS | -0.22 | 0.07 | -3.21 | | Diluted EPS | -0.22 | 0.07 | -3.21 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
